Abstract
Pharmacogenomics is a rapidly advancing field of science that studies how an individual's genetic makeup influences their response to drugs. This discipline has significant implications for personalized medicine, where treatments can be tailored to the genetic profile of each patient. Pharmacogenomics aims to optimize therapeutic efficacy and minimize adverse drug reactions by considering genetic variations in drug metabolism, receptor binding, and immune response. This article explores the role of pharmacogenomics in modern medicine, its application in clinical settings, and its potential for improving patient care. We also discuss challenges and future directions for this transformative field in precision medicine.
All articles published in the American Journal of Pharmaceutics are open access and licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows users to:
-
Share — copy and redistribute the material in any medium or format
-
Adapt — remix, transform, and build upon the material for any purpose, even commercially
Under the following terms:
-
Attribution — Appropriate credit must be given, a link to the license must be provided, and any changes must be indicated.
-
Authors retain full copyright of their work.
-
The journal does not restrict reuse of content, provided proper citation of the original publication is made.